Table 4.
Univariate analysis of incontinence
| Unmatched cohort |
PSM cohort |
|||||
|---|---|---|---|---|---|---|
| OR | 95% CI | P | OR | 95% CI | P | |
| TFL (vs. HL) | 1.44 | 1.052–1.953 | 0.021 | 0.765 | 0.483–1.204 | 0.249 |
| Age | 1.013 | 0.995–1.031 | 0.169 | 1.031 | 1–1.063 | 0.049 |
| Prostate volume (vs. 80–100 ml) | ||||||
| 101–200 ml | 1.221 | 0.86–1.769 | 0.277 | 1.702 | 0.705–5.076 | 0.281 |
| >200 ml | 1.251 | 0.713–2.143 | 0.422 | 2.277 | 0.764–7.733 | 0.156 |
| Preoperative indwelling catheter | 1.949 | 1.402–2.681 | <0.001 | 1.437 | 0.692–2.798 | 0.305 |
| Preoperative IPSS | 0.97 | 0.94–1.001 | 0.057 | 0.984 | 0.91–1.061 | 0.671 |
| Preoperative Qmax | 0.871 | 0.815–0.929 | <0.001 | 0.846 | 0.774–0.92 | <0.001 |
| Preoperative PVR | 1.005 | 1.003–1.006 | <0.001 | 1.005 | 1.003–1.008 | <0.001 |
| Enucleation type (vs. 3-lobe) | ||||||
| 2-lobe | 0.518 | 0.337–0.805 | 0.003 | 0.466 | 0.253–0.877 | 0.016 |
| En-bloc | 0.414 | 0.279–0.624 | <0.001 | 0.821 | 0.44–1.56 | 0.539 |
| Early apical release | 0.882 | 0.65–1.21 | 0.429 | 1.711 | 1.072–2.778 | 0.026 |
| Total operation time | 1.01 | 1.006–1.013 | <0.001 | 1.012 | 1.007–1.018 | <0.001 |
HL, holmium laser; IPSS, International Prostate Symptom Score; PSM; propensity score matched; PVR, post-void residual urine volume; Qmax, peak flow rate; QoL, quality of life score; SD, standard deviation; TFL, thulium fiber laser.